Back to company

Dan-Inject ApS: Financial statements 2023

CVR: 39736497

Dan-Inject ApS (CVR 39736497) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 8,542,605 and a net result of DKK 1,757,812 compared with DKK 1,466,464 the year before. That is an increase of 16.2% compared with the year before. Equity amounted to DKK 5,320,518. The solvency ratio was 27.2%. The company had 8 employees in the financial year.

Gross Profit
8,542,605 kr.
Profit/Loss
1,757,812 kr.
Equity
5,320,518 kr.
Total Assets
19,566,310 kr.
Employees
8

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023-8.5 mio.1.8 mio.5.3 mio.8
2022-7.4 mio.1.5 mio.3.6 mio.7
2021-7.2 mio.1 mio.2.5 mio.7
2020-6.3 mio.782 t.1.5 mio.6

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Dan-Inject ApS: The 2022 annual report is outMay 25, 2023

Dan-Inject ApS has published its annual report for 2022. Gross profit came to DKK 7,350,982, and the net result was DKK 1,466,464.

About Dan-Inject ApS

Dan-Inject ApS is a Danish company of the type Anpartsselskab based in Kolding, founded in 2018. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named SJS 2018 ApS. The management consists of Steffen Stræde. The company is owned by RAVN JENSEN HOLDING A/S, Saathi Holding ApS and Saga Holding ApS. The company has 2 employees. In 2025, the company reported a gross profit of DKK 7,084,282 and a net result of DKK 440,640 compared with DKK 69,179 the year before. Equity amounted to DKK 5,830,336.

Other financial years